Search
Highlights from the SWG
During 2023, the SWG:
Held a joint scientific meeting with the SWG on Myelodysplastic Syndromes and the SWG on Acute Myeloid Leukemia
Commenced work on guidelines for young MPN patients
Delivered a presentation for the American Society of Hematology (ASH) on the database…
Alliances & partnerships
EHA's approach to policy and regulatory affairs involves collaboration across medical professions and disciplines.
Read moreEHA-SWG Diagnosis Teaser Meeting
On February 17 the 'teaser' meeting "Join the conversation on integrated diagnosis" with Prof MC Béne and key opinion experts took place virtually. Missed the live teaser? No worries, you can still watch the recording until March 17, 2022.
Read moreKite and Gilead @EHA25 Virtual
We are proud to support the first ever EHA25 Virtual congress. Please join us & leading experts to learn about the latest in cell therapies and COVID-19.
Read moreDeadlines & Announcements
New announcements will be published as soon as new elements for the Congress Sponsor Program for EHA2025 are released.
Read moreSelected EMA news
March 2025New medicines recommended for approval
Lynozyfic (linvoseltamab)
Treatment of refractory multiple myeloma (a cancer of the bone marrow)
New information on approved medicines
Calquence (acalabrutinib) - new indication
Treatment of blood cancer
Columvi (glofitamab) - new indication
Treatment of blood cancer
Darzalex (daratumumab) - change of indication
Treatment…